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Copyright © 200? JCBN Summary The involvement of reactive oxygen species (ROS) in the pathophysiology of
Sjögren’s syndrome (SS), an autoimmune disorder, and irradiation-induced impairments in
salivary secretion has been reported. Meanwhile, the strong antioxidant astaxanthin (Ast)
has been suggested to have therapeutic effects on various diseases. In the present study, we
examined the ROS scavenging capacity of Ast using a human salivary gland epithelial cell
line (HSY) and investigated the effects of Ast on salivary secretion in a mouse model of
irradiation-induced salivary gland dysfunction. Furthermore, we performed a clinical study of
Ast in six SS patients and six normal individuals, quantifying the volume of saliva secretion
and the level of oxidative stress markers in the saliva. Ast partially suppressed hydrogen
peroxide-induced ROS in HSY cells. The mouse model demonstrated that the pre-
administration of Ast resulted in the suppression of irradiation-induced hyposalivation.
Furthermore, the administration of Ast appeared to increase salivary output in both the SS
and normal groups. The level of oxidative stress marker, hexanoyl-lysine, in the saliva was
reduced after Ast intake. These results suggest that Ast might act as an ROS scavenger,
providing benefits to SS patients with impaired salivary secretion.
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Introduction
Sjögren’s syndrome (SS) is an autoimmune disorder
characterized by lymphocyte infiltration and the destruction
of the lacrimal and salivary glands, accompanied by the
systemic production of autoantibodies to the ribonucleo-
protein particles SS-A/Ro and SS-B/La. The disease is not
fatal, but the dysfunction of the exocrine glands causes the
hyposecretion of tears and saliva, resulting in dry eyes and
dry mouth. These are common problems among the elderly,
and living with SS can be a devastating experience for the
sufferer, decreasing the quality of life dramatically. The
causes of SS have not yet been clarified; however, the
involvement of environmental factors and oxidative stress
from reactive oxygen species (ROS) [1] as well as genetic
factors, immune disorders, and viral infections has been
suggested in the onset and pathology of SS [2]. In particular,Effects of Astaxanthin for Salivary Secretion
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ROS such as superoxide and hydrogen peroxide are known
to induce apoptosis [3] and cause oxidative damage to
membrane proteins and lipids, leading to impaired func-
tioning [4]. Similar mechanisms have also been implicated
in the pathology of several diseases [5, 6]. Numerous reports
have discussed possible mechanisms whereby various
pathophysiological phenomena associated with autoimmune
diseases develop through these processes [7, 8]. For
example, increased levels of oxidative stress markers
have been found in the synovial fluid [9, 10], serum [11–13],
and urine of patients with rheumatoid arthritis [14] and
type I diabetes mellitus [15, 16].
Antioxidants are expected to serve as potentially
therapeutic agents for oxidative stress-related diseases.
Astaxanthin (Ast) is a reddish orange compound that
belongs to the carotenoid family, which is widely found in
fishes such as sea bream and salmon as well as crustaceans
such as crab and shrimp. An important function of
carotenoids such as Ast is to intercept the chlorophyll
triplet state, in order to prevent the formation of singlet
oxygen, or to quench the singlet oxygen molecule directly
[17, 18]. In recent years, the strong antioxidant action of
Ast has been implicated in preventive mechanisms for many
disorders [19, 20].
In this study, we examined the therapeutic effects of Ast
on impairments in salivary secretion in a mouse model of
irradiation-induced salivary hypofunction and SS patients
with xerostomia. As part of a clinical study, a gumdrop
containing Ast was administered to twelve subjects: six SS
patients with xerostomia and six normal individuals. To
investigate the capacity of Ast to scavenge intracellularly
generated ROS, we used a human salivary gland epithelial
cell line (HSY) and evaluated the amount of ROS generated
by H2O2 using flow cytometry.
Materials and Methods
Experimental animals
Six-month-old male C57BL6J mice were purchased
from Japan Clea Inc. (Tokyo, Japan) and maintained under
specific pathogen-free conditions until use. All the experi-
mental procedures were approved by the animal welfare
committee of Tsurumi University (Kanagawa, Japan).
Irradiation
Each mouse was anesthetized using an intraperitoneal
injection of 60 mg/kg sodium pentobarbital. A single acute
exposure to a 10-MV X rays (MEVATRON74 DX40;
Toshiba Medical Systems, Tokyo, Japan) at a dose rate of
3 Gy/min and a distance of 1,000 mm was performed. The
effective radiation dose to the salivary gland was set using
the percentage depth dose and was over 95% of the
maximum dose delivered.
Administration of Ast
The Ast was provided by Fuji Chemical Industry Co., Ltd
(Toyama, Japan). To examine the preventive and therapeutic
effects of Ast on impaired salivary secretion mediated by
ROS, the mice were freely fed food containing 2, 10 or
50 mg of Ast. In the model examining preventive effects,
free feeding was performed beginning two weeks before
irradiation and was continued until four weeks after irradia-
tion in the model examining therapeutic effects, free feeding
was performed for 4 weeks after irradiation.
Measurement of salivary secretion
The volume of saliva secreted by the Ast-treated mice was
measured. The amount of saliva secretion was measured 1
week prior to irradiation and was used to classify the animals
into administration groups with similar secretory capabilities.
The mice were weighed and then anesthetized using an
intraperitoneal injection of a mixture of xylazine (24 mg/kg)
and ketamine (36 mg/kg). To stimulate salivation, pilocarpine
(0.1 mg/kg) was injected intraperitoneally. The saliva
secreted into the oral cavity during each 1-min period
following the injection of pilocarpine was carefully collected
using capillaries (Ringcaps; Hirschmann Laborgeräte GmbH
& Co. KG, Eberstadt, Germany). The amount of total saliva
secreted in 15 min was divided by the weight of the mouse.
Human salivary gland epithelial cell cultures
HSY cells derived from an adenocarcinoma of the parotid
gland were used. HSY cells were cultured in growth medium
containing high-glucose Dulbecco’s modified Eagle’s
medium (DMEM) (D6429; Sigma, St. Louis, MO) plus 10%
fetal bovine serum (Sigma, St. Louis, MO) and 1% penicillin
or streptomycin (Invitrogen, Carlsbad, CA) and maintained
in a 100-mm culture dish in a humidified atmosphere
containing 5% CO2 at 37°C. Cells were allowed to grow to
80% confluence before being passaged in trypsin-EDTA
solution. The cells were then reseeded in a 100-mm culture
dish and grown for 24 h before use in the experiments.
Measurement of ROS using fluorescence-activated cell
sorting
We assessed ROS generation using the fluorescent probe
CM-H2DCFDA (5 mM), a dye that is sensitive to a broad
spectrum of ROS including H2O2 and ￿OH [21]. CM-
H2DCFDA is a cell permeant indicator for ROS that is non-
fluorescent until the removal of the acetate groups by
oxidation within the cell. Cells were grown at a density of
1 × 106 cells per well in a 12-well plate and were maintained
for 24 h in growth medium, then incubated for 1 h with Ast
(5 mM) or N-acetyl-cysteine (NAC) (5 mM) and exposed
for 15 min to CM-H2DCFDA. The HSY cells were then
exposed to 1.0 mM H2O2 for 30 min to analyze the intra-
cellular ROS level. Analyses were performed using aT. Yamada et al.
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FACSCaliber flow cytometer and Cell Quest software
(Becton Dickinson, Franklin Lakes, NJ).
Evaluation of Ast effects on SS patients and normal indi-
viduals
Tablets containing 2 mg of Ast extracted from
Haematococcus pluvialis were used (provided by Fuji
Chemical Industry Co., Ltd. Kamiichi-machi, Japan). Six
SS patients with xerostomia who had a salivary output of
less than 2 g, as determined using the Saxon test (SS group),
and six normal individuals (normal group) were examined
(Table 1). All twelve participants provided informed
consent. Each participant took six test tablets per day
(12 mg/day). Tests were performed before and 2 weeks after
the oral intake of the Ast tablets. Participants were instructed
not to eat food containing Ast during the examination
period. A piece of sterilized gauze was weighed before and
after being chewed by a participant for 2 min. The difference
between the two measurements (dry weight before chewing
and wet weight after chewing) was regarded as the salivary
output. Pre-treated saliva samples were centrifuged at
10,000 rpm for 30 min and then passed through an ultrafil-
tration membrane (pore size, 0.22 μm). The filtered samples
were subjected to an enzyme-linked immunosorbent assay
for the measurement of the oxidative stress marker 8-
hydroxy-2'-deoxyguanosine (8-OHdG) and the lipid per-
oxidation marker hexanoyl-lysine (HEL) using an anti-8-
OHdG monoclonal antibody (N45.1; Institute for the
Control of Aging, Shizuoka, Japan) and an anti-HEL mono-
clonal antibody (Institute for the Control of Aging, Shizuoka,
Japan), respectively. The primary antibodies bound to the
markers were probed with an HRP-conjugated anti-mouse
IgG antibody (Zymed Laboratories, South San Francisco,
CA) and assessed by measuring the color development at
490 nm.
Statistical analysis
All the results were expressed as the mean ± SE. The
Wilcoxon’s rank-sum test was performed to compare the
results before and after the intake of the Ast tablets. Data
were analyzed for statistical significance, and the signifi-
cance level was set at a p value<0.05.
Ethics
Informed consent was obtained from all the patients, and
the Ethical Committee of Tsurumi University approved this
study.
Results
Comparison of Ast effects on irradiation-induced impaired
salivary secretion
The present study showed that salivary flow had decreased
at 1 week after irradiation in the control group, which was
fed a conventional chow (Fig. 1). This result is consistent
with that of a previous report. The administration of a high
dose of Ast (50 mg/day) before irradiation resulted in the
suppression of the salivary impairment observed in the
control group at 3 and 4 weeks after irradiation (Fig. 1A).
However, when Ast was administered after irradiation, the
salivary secretion did not recover (Fig. 1B). These findings
indicate that Ast has a preventive, but not a therapeutic,
effect on irradiation-induced salivary dysfunction.
Confirmation of antioxidant activities of Ast and NAC using
fluorescence-activated cell sorting flow cytometry
The intracellular generation of ROS at 20 min after the
addition of H2O2 was measured using CM-H2DCFDA as a
fluorescent indicator of ROS, such as H2O2 and hydroxyl
radicals. The mean fluorescence intensity (MFI) of H2O2-
stimulated HSY cells was elevated (MFI = 485.04). Pre-
treatment with Ast partially suppressed the H2O2-induced
MFI elevation (MFI = 117.51). Although the lower-phase
intensity was not changed, the higher-phase intensity was
almost completely inhibited (Fig. 2B). This result suggests
the possibility that Ast scavenges some species of ROS
induced by H2O2. On the other hand, pre-treatment with
NAC, scavenges wide variety of ROS including H2O2 and
￿OH via glutathione generation [22], reverted the H2O2-
induced MFI elevation to the unstimulated levels (MFI =
18.11) (Fig. 2A).
Effects of Ast on saliva secretion and oxidative stress
markers in SS patients and normal individuals
The involvement of oxidative stress in salivary gland
dysfunction has been reported [1]. When the SS group was
compared with the normal group, the levels of both 8-OHdG
and HEL were significantly higher in the SS group than in
the normal group (p = 0.008 and p = 0.005, respectively)
(Fig. 3). This result was consistent with those of previous
studies [1]. To evaluate the effects of Ast on salivary secre-
tion and ROS production in SS patients, we measured the
amount of salivary secretion and the level of 8-OHdG and
HEL in saliva before and after examination. Although the
increased amount of salivary secretion after the intake of
Ast for 2 weeks was faint in the SS group (1.02 g/2 min to
Table 1. Characteristic of the subjects in this study
Values represent mean ± SEM.
SS: Sjögren syndrome
SS Normal
(n =6 ) ( n =6 )
age (years) 64.7 ± 6.4 28.5 ± 4.0
saliva flow rate (g/2 min) 1.02 ± 0.4 6.2 ± 2.2Effects of Astaxanthin for Salivary Secretion
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1.04 g/2 min, p = 0.69) (Fig. 4A), a significant increase was
observed in the normal group (6.23 g/2 min to 7.02 g/2 min,
p = 0.03) (Fig. 4B). The level of the oxidative stress marker
8-OHdG did not change in either group (Fig. 5, left panels of
A and B). However, the alternative oxidative stress marker
HEL was significantly decreased in SS group (34.0 M to
30.58 M, p = 0.03) (Fig. 5, right panel of A). The decreased
HEL level in the normal group was faint (Fig. 5, right panel
of B). This suggests that the elevated stress marker levels
shown in this study were not caused by hyposalivation.
These results suggest that Ast administration has a beneficial
effect on salivation in not only patients with SS, but also in
normal individuals by inducing the scavenging of ROS.
Discussion
The possible causes of hyposalivation include organic
disorders of glandular tissues, as exemplified by the auto-
immune disease SS, as well as the adverse effects of drugs,
pollution, and aging. High levels of oxidative stress markers
such as 8-OHdG and HEL in the saliva of SS patients [1] and
the involvement of ROS in the mechanism of irradiation-
induced hyposalivation [23] have been reported. These
findings suggest that the oxidative stress induced by various
environmental factors causes salivary gland dysfunction
[24]. Ast, a member of the carotenoid family, has been
reported to have an extremely high level of antioxidant
activity and to act as a scavenger of oxygen radicals [25].
For this reason, the clinical studies of Ast have been
accumulated [26–28]. Satoh et al. showed the safety of
Fig. 1. Effect of Ast on salivary secretion. A) Model examining preventive effects. Ast at a dose of 2 mg/kg, 10 mg/kg or 50 mg/kg was
administered intravenously 2 weeks prior to irradiation and once a day beginning on the day after irradiation and continuing for
4 weeks. B) Model examining therapeutic effects. Ast at a dose 2 mg/kg, 10 mg/kg or 50 mg/kg was administered intravenously
after irradiation and once a day beginning on the day after irradiation and continuing for 4 weeks. Saliva flow was expressed as
the total output of saliva during the first 15 min after pilocarpine stimulation, normalized to the body weight. The asterisks
indicate a significant decrease (*p<0.05), compared with the respective control.
Fig. 2. Flow cytometry analysis of ROS. HSY cells were
incubated for 1 h with NAC (5 mM) (A) or Ast (5 mM)
(B) and then exposed for 15 min to CM-H2DCFDA.
ROS generation was assessed after exposure to 1.0 mM
H2O2 for 30 min.T. Yamada et al.
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new Ast-product and the efficiency of Ast on age-related
decline in cognitive and psychomotor functions. Therefore,
we examined the effects of Ast on the ROS scavenging
capacity and the possible therapeutic effect of Ast on
salivary gland dysfunction. We found that the levels of the
oxidative stress markers 8-OHdG and HEL were signifi-
cantly higher in the SS group than in the normal group
(Fig. 3) and that the level of HEL in the SS group was
significantly reduced by the intake of Ast (Fig. 5A). These
results suggest that oxidative stress may be a cause of
salivary gland dysfunction in SS. Although the Ast-induced
inhibition of HEL in the SS group was higher than that in the
normal group (Fig. 5), the effect of Ast on salivation was
faint in the SS group but significant in the normal group
(Fig. 4). These inconsistencies might have arisen for several
reasons. First, the level of ROS production in the SS group
might be too high to be compensated for by Ast under the
study conditions, including the dose and/or term of treat-
ment. Second, the species of ROS affecting salivary function
might be generated as a byproduct of normal cellular
respiration, associated primarily with mitochondrial electron
transport [29]. In the SS group, in addition to the above
mechanism, ROS might be generated following cell lysis
and the oxidative burst produced by the immune response
[30, 31]. Therefore, the increase in salivation in the SS group
was not as strong as expected.
Takeda et al. [23] reported that NG-monomethyl-L-arginine
(L-NMMA), a nitric oxide synthase inhibitor, alleviated
hyposalivation in irradiated mice and inferred that nitrogen
monoxide was involved in the impairment of salivary
secretion. Based on these findings and the fact that Ast
inhibits nitrogen monoxide synthesis [32], the alleviation of
hyposalivation by Ast in an irradiation-induced hyposaliva-
tion mouse model shown in the present study (Fig. 1) might
be due to a defense mechanism involving the inhibition of
nitrogen monoxide synthesis. However, Ast did not show a
therapeutic effect on irradiation-induced hyposalivation.
Thus, the scavenging of ROS generated at the time of
Fig. 3. 8-OHdG (p = 0.008) and HEL (p = 0.005) levels of saliva in both groups. These levels were significantly higher in the SS group
than in the normal group. The asterisks indicate significant increases (**p<0.005). Values are the mean ± SEM. A) SS group,
B) normal group.
Fig. 4. Measurement of salivary output upon stimulation using the Saxon test. In the normal group treated with Ast, the saliva flow rate
after 2 weeks of treatment was significantly higher than that at baseline. The asterisks indicate a significant increase (*p<0.05).
Values are the mean ± SEM. A) SS group, B) normal group.Effects of Astaxanthin for Salivary Secretion
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irradiation may be crucial. In the patients with SS, the reduc-
tion in HEL might have resulted from the Ast-induced
scavenging of newly generated ROS, which accounts for a
small portion of the total HEL in the saliva of patients with
SS. Therefore, treatment with Ast might be useful in patients
with salivary dysfunction associated with SS to prevent
the condition from worsening.
The expression of various inflammatory cytokines
including IL-1, IL-2, IFNγ and TGFβ, cell adhesion
molecules, and chemokines is detected in salivary gland of
SS patients [33–35]. In normal human mesangial cells
(NHMCs), Ast suppresses high glucose induced ROS pro-
duction. Accompanied with ROS production, Ast suppresses
the activation of nuclear transcription factors such as
nulclear factor kappa B (NFκB) and activator protein
(AP-1), and the expression of transforming growth factor-
beta 1 (TGFβ1), and monocyte chemoattractant protein-1
(MCP-1) [36]. Thus, Ast may be effective in the cytokine
production following tissue destruction in the salivary gland
of SS patients resulting in reduced salivary dysfunction.
Impairments in salivary secretion affect the quality of life
and also cause various functional impairments, including
dental caries, periodontal diseases, upper gastrointestinal
disorders, aspiration pneumonia, dysphagia and infectious
diseases. Therefore, the development of a medicine for
impaired salivary secretion is of great significance, and Ast
is a potent candidate for such a remedy. We plan to perform
further clinical evaluations using a larger number of cases
and to clarify the details of the mechanism of impaired
salivary secretion in the future.
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